Artwork

Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Molecular DX Europe 2015 | COLD-PCR for Liquid Biopsy: Current Impact and Future Directions

15:35
 
Share
 

Manage episode 68803440 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
CHI sits down with Dr. Mike Makrigiorgos of Dana Farber and Brigham to discuss a new COLD-PCR method (temperature tolerant COLD-PCR) that uses targeted re-sequencing to detect mutations as low as .01-.1%. In this podcast, Dr. Makrigiorgos discusses the science behind COLD PCR, gives a preview of his talk at the April cfDNA conference in Lisbon, and discusses the future impact of liquid biopsy.
  continue reading

255 episodes

Artwork
iconShare
 
Manage episode 68803440 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
CHI sits down with Dr. Mike Makrigiorgos of Dana Farber and Brigham to discuss a new COLD-PCR method (temperature tolerant COLD-PCR) that uses targeted re-sequencing to detect mutations as low as .01-.1%. In this podcast, Dr. Makrigiorgos discusses the science behind COLD PCR, gives a preview of his talk at the April cfDNA conference in Lisbon, and discusses the future impact of liquid biopsy.
  continue reading

255 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide